Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 EUR | +5.22% | +2.29% | -86.40% |
Sales 2024 * | 39.35M 36.56M | Sales 2025 * | 58.17M 54.04M | Capitalization | 84.6M 78.59M |
---|---|---|---|---|---|
Net income 2024 * | -119M -111M | Net income 2025 * | -78M -72.46M | EV / Sales 2024 * | -1.09 x |
Net cash position 2024 * | 127M 118M | Net cash position 2025 * | 54.53M 50.66M | EV / Sales 2025 * | 0.52 x |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
-1.49
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | +0.71% | ||
Current month | +7.63% | ||
1 month | +11.90% | ||
3 months | -82.26% | ||
6 months | -81.81% | ||
Current year | -85.69% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Date | Price | Change |
---|---|---|
24-06-10 | 1.41 | +5.22% |
24-06-07 | 1.34 | -0.74% |
24-06-06 | 1.35 | +2.27% |
24-06-05 | 1.32 | -2.22% |
24-06-04 | 1.35 | -3.57% |
Delayed Quote Börse Stuttgart, June 10, 2024 at 03:13 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock